Bryant Henry Uhlman

No ORCID on file · 330 papers in corpus
2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

2000

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …